Topics

  • YAKUGAI Ombudsperson
  • Tie-up Group
2023-01-31
Opinion against Partnership Agreement between the Tokyo Metropolitan Government and Pfizer Japan
2023-01-18
Request for Correction to Misidentification in Niigata University’s public relations article on the "Large epidemiologic study to evaluate the efficacy and safety of HPV vaccination against cervical cancer in Japan" (NIIGATA Study) and Verification of the Cause of the Misidentification
2022-11-21
We oppose the emergency approval of Shionogi's COVID-19 drug Xocoba
2022-06-20
Opinion against emergency approval of Shionogi's COVID-19 drug
2022-04-04
Fourth Opinion on Avigan - Request To Stop Stockpiling Avigan And Revoke Its Approval
2022-03-01
Opinion against the appointment of a Pfizer Japan Executive Officer as a member of the Tokyo Metropolitan Board of Education
2021-11-18
Statement: Opposition to reinstatement of the active recommendation of HPV vaccinations and call for relief for victims
2021-09-13
Third Opinion Requesting the Immediate Suspension of the Avigan “Observational Study” in Light of the High Mortality Rate of Patients Treated with Avigan
2021-07-06
OPEN LETTER: Request for GACVS transparency on members’ conflicts of interest
2020-07-02
Second Opinion on Avigan Based on Deaths Mentioned in 'the Interim Report of The Favipiravir Observational Study' by Fujita Health University (Regarding Covid-19)
2020-05-01
Opinion on Avigan (regarding COVID-19)
2018-08-13
Critical Opinion on Cochrane Review of HPV Vaccines
2018-06-11
Opinion on Sadao Suzuki's paper on the Nagoya City Cervical Cancer Immunization Survey
2018-04-26
Internet video delivery of the international symposium” The Current Status of Worldwide Injuries from the HPV Vaccine"
2018-04-26
Joint Statement 2018 for the Victims of HPV Vaccines
2018-03-26
International symposium hosted by Medwatcher Japan "The Current Status of Worldwide Injuries from the HPV Vaccine" was a great success
2018-01-24
International Symposium: "The Current Status of Worldwide Injuries from the HPV Vaccine"
2017-11-02
Submission of requests to MHLW (Ministry of Health, Labour and Welfare) on amendments to the “Precautions for Use” column on the package inserts of benzodiazepine type drugs
2017-06-12
“Lessons learnt in Japan from adverse reactions to the HPV vaccine: a medical ethics perspective” published in IJME
2016-11-02
Open letter on the Discussion Meeting on Cervical Cancer Prevention Vaccines submitted to MHLW
2016-11-02
Submission of "Refutation of GACVS (Global Advisory Committee on Vaccine Safety) statement on Safety of HPV vaccine on December17, 2015"
2016-07-21
Submission of requests to JPMA (Japan Pharmaceutical Manufacturers Association) and JAMS (Japanese Association of Medical Sciences) on DOACs (NOACs); and receipt of replies from 5 companies and 3 relevant societies
2016-07-04
Submission of “The opinion document against Expertise of a related academic association relating to propulsive movement of Human Papillomavirus（HPV）vaccine (Preventive Vaccine for Cervical Cancer) “
2016-05-12
Submission of “Statement against Starting Hepatitis B Vaccines Program”
2016-05-11
Submission of “Requests on the Kaketsuken’s Misconducts in Manufacturing”
2016-03-03
Sent an open letter on COI issues with “Guidelines for Pharmacotherapy of Atrial Fibrillation (JCS 2013)”
2016-03-03
Submission of “ Statement on Prazaxa (dabigatran)”
2015-12-17
Submission of “Statement on the ‘Preliminary Report of Analysis of Nagoya City Cervical Cancer Immunization Program Survey’”
2015-12-01
Submission of Statement on the “Epidemiological study to evaluate the efficacy and safety of HPV vaccines (cervical cancer vaccines)” to evaluate the efficacy and safety of HPV vaccines (cervical cancer vaccines)”
2015-11-23
Symposium "Problems with the HPV Vaccine" -- Reports from Japan and Overseas --
2015-11-11
Submission of “Opinions on the suggested gist for the partial amendment of ‘Ministerial Ordinance on Good Clinical Practice’”
2015-10-28
Submission of written request regarding benzodiazepine type drugs
2015-04-21
Release of a statement criticizing an HPV JAPAN appeal
2015-04-01
Publication of the Second Collection of Reports on Damages from HPV Vaccine (Cervical Cancer Vaccine) Advers Reactions
2015-02-26
Filed a complaint against HPV vaccine manufacturers on suspicion of violations of JPMA Promotion Code for Prescription Drugs
2014-07-27
Symposium " Consideration of Pharmacovigilance --Lessons from the adverse effect of HPV vaccination"
2014-06-02
Publication of a Collection of Reports on Damages from HPV Vaccine (Cervical Cancer Vaccine) Advers Reactions
2014-04-28
Submission of a “Request to reconsider the rules on conflict of interest (COI) for Ministry of Health, Labour and Welfare councils - In light of the COI issues with council members regarding HPV vaccines”
2014-03-01
Regarding the deliberations at Discussion Meeting and the Health Sciences Council meeting, MHLW on HPV vaccines (cervical cancer vaccines) on February 26th
2014-02-24
Submission of Position Document, “Critique against MHLW Deliberation Results on HPV Vaccines (Cervical Cancer Vaccines) -Medwatcher Japan Strongly Opposes Resuming Active Recommendation for HPV Vaccination-”
2013-11-01
Criminal complaint filed against Novartis Pharma KK over the Diovan Incident
2013-09-25
Submission of a written request on the cervical cancer vaccine (Human Papilloma Virus or HPV vaccine)
2013-09-11
The release of written opinions on the Diovan Data-Manipulation Scandal
2013-02-26
Submission of a written request concerning prevention of misconduct in medical research
2013-02-19
Submission of a written request over Transparency Guideline for the Relation between Corporate Activities and Medical Institutions
2006-12-03
10th Memorial Symposium of HIV Litigation Settlement December 3, 2006 (Guest speaker: David Healy)

more